Back to results
US 12,497,386 B2Granted
Estrogen receptor-modulating compounds
AssigneeRadius Pharmaceuticals, Inc.
InventorChris Miller
Life of this patent
Estimating the term…
Abstract
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
Claims7
A compound selected from:
- 1-(4-(2-((Cyclopropylmethyl)amino)ethyl) benzyl)-2-(4-methoxyphenyl)-3-methyl-1H-indol-5-ol;
- 1-(4-(2-((Cyclopropylmethyl)amino)ethyl)benzyl)-3-fluoro-2-(o-tolyl)-1H-indol-5-ol;
- and
- 2-Fluoro-N-(4-((8-fluoro-7-(o-tolyl)pyrrolo [3,2-e]indazol-6 (3H)yl)methyl) phenethyl)ethan-1-amine.
1 more element
Dependencies are inferred from the claim text.